Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Solaris Vaccines announced it raised $110,000 in an initial filing from an offering of $200,000
PRIVATEMay 19, 2023•over 3 years ago
Amount Raised
$110,000
Round Type
Pre-Seed
Fort CollinsOther
Company Information
Company
Solaris Vaccines
Location
320 E. VINE DRIVE
Fort Collins, Colorado, United States
About
Addressing the significant threat to global health posed by current and future pathogens is a critical unmet need laid bare by the ongoing pandemic. Both traditional and emerging approaches to creating vaccines have limitations, and new options are urgently required. Solaris is applying a technology previously used for inactivating pathogens in the blood supply to rapidly produce safe and effective vaccines against viruses, bacteria and parasites under the trade name SolaVAX™.
Don't miss Solaris Vaccines's next move
Get an email the moment Solaris Vaccines raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contacts2 people are listed at Solaris Vaccines. We don't have their email yet.
Predictive Intelligence
Strategic
ML-powered predictions for Solaris Vaccines's next move
Fort CollinsOther